2025
|
Invention
|
Cell culture media containing combinations of proteins.
The present invention relates to methods... |
|
G/S
|
Recombinant cytokine proteins for research use; Recombinant cytokine proteins for use in manufact... |
2022
|
G/S
|
Cell culture media for laboratory use; cell culture media
for use in scientific research; non-an... |
|
G/S
|
Cell culture media for laboratory use; cell culture media for use in scientific research; non-ani... |
|
Invention
|
Cell culture media containing combinations of proteins. The present invention relates to cell cul... |
2021
|
Invention
|
Cell culture media containing combinations of proteins. The present invention relates to methods ... |
2020
|
G/S
|
Recombinant albumin in the nature of excipients for use in the manufacture of pharmaceutical prep... |
|
G/S
|
Recombinant albumin in the nature of excipients for use in
the manufacture of pharmaceutical pre... |
|
Invention
|
Lactoferrin compositions and methods for modulation of t cell subtypes and treatment of autoimmun... |
2019
|
G/S
|
Chemicals, namely, non-animal derived cell culture media
supplement to promote cell growth and p... |
|
G/S
|
Biochemical reagents used for non-medical purposes, namely,
microbial cell lysis reagents used i... |
|
G/S
|
Recombinant human serum albumin for industrial use, namely,
for use in the manufacture of cell c... |
2018
|
G/S
|
Cell culture media and media components for scientific and
research use, namely, for development... |
|
G/S
|
Cell culture media supplement for laboratory use; cell culture media supplement for use in scient... |
|
G/S
|
Cell culture media and cell culture media components for scientific and research use, namely for ... |
|
G/S
|
Biochemical reagents used for non-medical purposes, namely, microbial cell lysis reagents used in... |
|
G/S
|
Recombinant transferrin derived from a non-mammalian host for industrial use, namely, for use in ... |
|
G/S
|
Recombinant human lactoferrin derived from a nonmammalian host for use in cell culture media for ... |
|
G/S
|
Recombinant human serum albumin for industrial use, namely, for use in the manufacture of cell cu... |
2015
|
Invention
|
Non-glycosylated transferrin expressed in monocots.
Disclosed are compositions and methods of ma... |
2014
|
Invention
|
Ospa fusion protein for vaccination against lyme disease.
Provided herein are monocot seed compo... |
2012
|
Invention
|
Monocot seed product comprising a human blood protein. The invention is directed to blood protein... |
2011
|
Invention
|
Non-glycosylated transferrin expressed in monocots. Disclosed are compositions and methods of mak... |
|
Invention
|
Lactoferrin. A pure lactoferrin polypeptide containing no more than two metal ions per molecule, ... |
|
Invention
|
Methods & compositions for improving protein production.
The invention relates to compositions, ... |
2010
|
Invention
|
Methods and compositions comprising heat shock proteins. Compositions, and uses thereof, which ar... |
|
Invention
|
Lactoferrin.
A pure lactoferrin polypeptide containing no more than two metal ions per molecule,... |
|
Invention
|
Monocot seed product comprising a human serum albumin protein. The invention is directed to monoc... |
|
Invention
|
Cell culture media containing combinations of proteins.
The present invention relates to cell cu... |
2009
|
Invention
|
Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions.
LDL recepto... |
|
Invention
|
Expression of human milk proteins in transgenic plants.
The invention is directed to food and fo... |
|
G/S
|
Chemicals, namely, non-animal derived cell culture media supplement to promote cell growth and pr... |
|
Invention
|
Production of ospa for lyme disease control.
The present invention relates, generally, to the pr... |
2008
|
Invention
|
Expression of human milk proteins in transgenic plants. The invention is directed to seed and see... |
|
Invention
|
Recombinant lactoferrins, methods of production from plants and uses thereof. The invention conce... |
2007
|
Invention
|
Human blood proteins expressed in monocot seeds.
The invention is directed to blood proteins pro... |
|
Invention
|
Compositions containing lactoferrin, and methods of using same to promote growth of skin cells.
... |
2006
|
G/S
|
Biochemicals, namely, genetically engineered transgenic cereal grain, extracts of transgenic cere... |
|
Invention
|
Use of lactoferrin fragments and hydrolysates.
The present invention relates to use of at least ... |
|
Invention
|
Oral formulations for enteric disorders and/or rehydration.
The present invention relates, gener... |
|
Invention
|
Components of cell culture media produced from plant cells.
The present invention comprises the ... |
2005
|
Invention
|
Plant transcription factors and enhanced gene expression. The invention relates to transgenic pla... |
2003
|
Invention
|
Production of human growth factors in monocot seeds. Production of human growth factors in the se... |
|
Invention
|
Method of making an anti-infective composition for treating oral infections. This invention conce... |
|
Invention
|
Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions. LDL receptor... |
|
Invention
|
Expression of human serum albumin (hsa) in monocot seeds. A method of producing human serum album... |
2002
|
Invention
|
Expression of human milk proteins in transgenic plants. The invention is directed to food and foo... |
|
Invention
|
Feed additive compositions and methods. The invention is directed to improved animal feed composi... |
2001
|
Invention
|
Plant selectable marker and plant transformation method. A plant transformation vector for transf... |
2000
|
Invention
|
Recombinant lactoferrin, methods of production from plants and uses. The invention concerns the u... |
1999
|
Invention
|
Plant selectable marker and plant transformation method. A plant transformation expression casset... |
1998
|
Invention
|
Method of barley transformation. A method for stably transforming barley from mature barley seeds... |